Sunset Capital Assets, Inc. (SNST) (OTC PINK:SNST) is pleased to announce that it has entered into a non-binding letter of intent dated June 12, 2020 with Aphex BioCleanse Systems , Inc. pursuant to which the parties will proceed towards a complete merger.
Transaction
The final elements of the Transaction will be determined by the parties following the completion of final due diligence. The transaction is expected to have final closing by the end of July 2020. Under the terms of the LOI, all of the issued and outstanding stock, in all classes of Aphex BioCleanse Systems are anticipated to be exchanged for common shares of the Public Issuer, Sunset Capital: The Company.
Effective at the closing of the Transaction, the current members of the board of directors of Aphex BioCleanse Systems will join the board of directors of the Company and the Company Directors will resign. The existing management team of Aphex BioCleanse Systems will replace the current management of the Company who will also resign.
Aphex BioCleanse Systems
Aphex BioCleanse Systems, Inc., based in Rochester NY, has developed a revolutionary disinfectant germ, virus and bug killing formulation under the Trade Name Hy-IQ which is produced through a Proprietary Trade Secret manufacturing process. Hy-IQ kills germs, viruses and even larger bugs by marshalling the natural forces of Hydrogen in a methodology never believed possible to be produced in larger scale Commercial Manufacturing Production. The base Hy-IQ formula contains no alcohol, chlorine or other chemicals, and relies on physics, not chemicals or Chemistry to kill germs, viruses and bugs. Aphex, Hy-IQ has been proven to effectively eliminate many viruses, bacteria, molds, fungi and other "bugs". David Weaver, the CEO of Aphex, says, "Hy-IQ is positioned to revolutionize the disinfecting and pesticide world at a level that can best be described as revolutionary. We at Aphex are excited about the potential to merge our Company and amazing technology into Sunset and look forward to a successful conclusion to the merger process". To learn more about Aphex and the revolutionary products, please visit online at www.aphexus.com.
Sunset Capital Assets
Sunset Capital Assets has operated as a boutique, global, investment and advisory firm headquartered in Jacksonville, FL and founded in 2012. Sunset has taken a pioneering, consulting-based approach to corporate equity investing, partnering with management teams to work to build value. Sunset Title Corporation has been in successful operation for many years. Its management has determined that the best way to responsibly build share holder value is to align itself with Aphex, whose unique and distinguished technology and global market potential could have a significant impact to its overall public capital structure.
